The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Merck Serono; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Medison; MSD; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Medison; MSD; Novartis; Pfizer
A phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi sarcoma (CKS).
 
Alona Zer
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; MSD; Roche
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD; Roche
 
Oded Icht
No Relationships to Disclose
 
Lilach Joseph
No Relationships to Disclose
 
Dana Avram
No Relationships to Disclose
 
Oded Jacobi
Travel, Accommodations, Expenses - AstraZeneca
 
Eyal Fenig
No Relationships to Disclose
 
Noga Kurman
No Relationships to Disclose
 
Idit Peretz
No Relationships to Disclose
 
Sivan Shamai
No Relationships to Disclose
 
Ofer Merimsky
Honoraria - Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; Progenetics; Roche
Consulting or Advisory Role - NeoPharm
 
Eitan Ben-Ami
No Relationships to Disclose
 
Roni Shapira
No Relationships to Disclose
 
Anna Ewa Schwarzbach
Employment - Tempus
Stock and Other Ownership Interests - Tempus
 
Hanna Bernstine
No Relationships to Disclose
 
Rony Weitzen
No Relationships to Disclose
 
Olga Vornicova
No Relationships to Disclose
 
Gil Bar-Sela
No Relationships to Disclose
 
Salomon M. Stemmer
Stock and Other Ownership Interests - canfite; CTG Pharma; DocBoxMD; tyrnovo; VYPE
Consulting or Advisory Role - Novartis
Research Funding - AstraZeneca (Inst); BiolineRx (Inst); Bristol-Myers Squibb (Inst); Can-Fite BioPharma (Inst); Clovis Oncology (Inst); CTG Pharma (Inst); Exelixis (Inst); Geicam (Inst); Halozyme (Inst); Incyte (Inst); Lilly (Inst); Moderna Therapeutics (Inst); MSD (Inst); Puma Biotechnology (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Silenseed (Inst); SynCoreBio (Inst); Teva (Inst); Tiziana Life Sciences (Inst)
Travel, Accommodations, Expenses - Genomic Health
 
Michal Lotem
No Relationships to Disclose